Efficacy of High-Dose Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Glycemic Parameters in Patients With Type 2 Diabetes Estimated With Continuous Glucose Monitoring: A Pilot Study

Integrative Obesity and Diabetes
doi 10.15761/iod.1000176
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Open Access Text Pvt, Ltd.

Related search

Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2006English

Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes Mellitus

Frontiers in Pharmacology
Pharmacology
2017English

Cost-Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Monotherapy in Elderly Type 2 Diabetes Patients in Thailand

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2016English

A Randomized, Placebo- And Sitagliptin-Controlled Trial of the Safety and Efficacy of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Japanese Patients With Type 2 Diabetes

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Suppression of Abdominal Aortic Aneurysm Formation in Mice by Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2018English

Role of Dipeptidyl Peptidase-4 Inhibitor in the Control of Glycemic State in Type I and Type II Diabetes Mellitus in Rats: A Comparative Study

The Medical Journal of Cairo University
2018English

Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors for the Treatment of Type 2 Diabetes Mellitus

Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
2016English

Prevalence and Extent of Glycemic Excursions in Well-Controlled Patients With Type 2 Diabetes Mellitus Using Continuous Glucose-Monitoring System

Indian Journal of Medical Sciences
Medicine
2009English

Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy